Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6atac small nuclear 28, pseudogene (RNU6ATAC28P) is a noncoding pseudogene located on chromosome 14q31.2, annotated as a small nuclear RNA (snRNA) pseudogene[1][3]. Pseudogenes are genomic DNA sequences similar to normal genes but usually non-functional; many are unprocessed or processed gene remnants[5]. While most pseudogenes do not produce functional proteins, some pseudogene transcripts may be transcribed into RNA, with emerging evidence suggesting they can modulate gene expression by acting as sources of regulatory RNAs or as decoys for microRNAs[5][7]. RNU6ATAC28P itself has no known protein product, receptor, enzyme, or transporter function, and currently no evidence links it directly to any therapeutic mechanism or drug interaction[1][3]. It is not considered a therapeutic target, and it has no recognized role as a biomarker or in specific diseases, although pseudogene dysregulation may contribute to broad disease mechanisms, especially in cancer biology by affecting the regulation of functional genes through RNA-based mechanisms[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 28, pseudogene (RNU6ATAC28P).